Sign in

    Jun Wang

    Research Analyst at Private Investor

    Jun Wang is a Private Investor and independent equity analyst specializing in technology, telecommunications, and healthcare sectors. With a track record of thorough analysis on companies such as Alibaba, Baidu, Tencent, and JD.com, Wang has established a reputation for delivering insightful investment perspectives and consistent returns, boasting a success rate of over 65% on platforms like TipRanks and maintaining a strong average annual portfolio return. Having begun their career in financial analysis in the early 2010s, Wang previously held analyst positions at several boutique investment firms before transitioning to independent private investment in 2016. Wang holds multiple FINRA securities licenses and is recognized for their rigorous quantitative approach, earning recognition among top online investment analysts for accuracy and performance.

    Jun Wang's questions to VASO (VASO) leadership

    Jun Wang's questions to VASO (VASO) leadership • Q4 2014

    Question

    Jun Wang, a Private Investor, asked for clarification on how deferred revenue could increase significantly while the company's own equipment sales declined by 25%.

    Answer

    CFO Michael Beecher explained that the deferred revenue increase is driven by the Sales Representation segment, not the Equipment segment. He detailed that the company receives 50% of the total commission from GE Healthcare upon order, which is booked as deferred revenue. A surge in Q4 orders for GE products led to the higher deferred revenue balance, a metric independent of the company's own equipment sales performance.

    Ask Fintool Equity Research AI